MedTrace Logo

Follow up of LEAP Participants and Their Families

NCT03546413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1868

Last updated 2024-03-29

Study results available
· View outcomes & findings →

Summary

This prospective, cross-sectional study was designed to improve understanding of how early-life introduction of peanuts may promote the maintenance of tolerance in adolescence and will serve as an additional safety evaluation of the original nutritional intervention.

Conditions

Sponsors & Collaborators

  • Immune Tolerance Network (ITN)

    collaborator NETWORK

  • PPD Development, LP

    collaborator INDUSTRY

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Gideon Lack, MD · Evelina Children's Hospital, Guy's and St. Thomas's NHS Foundation Trust

Eligibility

Min Age
0 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-05
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03546413 on ClinicalTrials.gov